Pfizer asks FDA to OK fourth dose of COVID vaccine for seniors
CBSN
Pfizer and BioNTech have asked the Food and Drug Administration to greenlight a fourth dose of their COVID-19 vaccine for Americans 65 and older, the companies announced Tuesday, citing data from Israel suggesting that the additional booster could curb infections and severe illness in the highest-risk age group
"Right now, the way that we have seen, it is necessary, a fourth booster right now," Pfizer CEO Albert Bourla told "Face the Nation" in an interview that aired Sunday.
In a release on Tuesday, Pfizer and BioNTech pointed to an array of recently published studies as early evidence suggesting "that effectiveness against both symptomatic COVID-19 and severe disease caused by Omicron wanes 3 to 6 months after receipt of an initial booster."
Washington — Former Republican Rep. Matt Gaetz is meeting with senators on Capitol Hill on Wednesday as he seeks to shore up support for his nomination for attorney general amid calls for the House Ethics Committee to release a report on allegations he engaged in sexual misconduct and illicit drug use.